Sign in

CIK 0001641281

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Bolt Biotherapeutics, Inc.

Sign in to watch
Ticker
BOLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472804636
Phone
+1 650-665-9295
Business address
900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
Bolt Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Chief Medical Officer bought 1,328 shares at an average $12.93 ($17,175)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy Chief Financial Officer bought 6,256 shares at an average $7.04 ($44,067)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy 10% owner bought 400,000 shares at $20.00 ($8,000,000)
  14. 4 Open-market buy 10% owner bought 450,000 shares at $20.00 ($9,000,000)
  15. 4 Open-market buy 10% owner bought 350,000 shares at $20.00 ($7,000,000)
  16. 4 Open-market buy Director bought 1,200 shares at $20.00 ($24,000)
  17. 4 Open-market sale Director sold 62 shares at $20.00 ($1,240)
  18. 4 Open-market buy Director bought 450,000 shares at $20.00 ($9,000,000)
  19. 4 Open-market buy Director bought 2,200 shares at $20.00 ($44,000)
  20. 4 Open-market buy Director bought 200,000 shares at $20.00 ($4,000,000)

Page 6 of 8 · 142 filings